The protective and immunomodulatory effects of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus infection in mice

A. A. Durgaryan, M. B. Matevosyan, Y. Seferyan, M. A. Sargsyan, S. L. Grigoryan, A. A. Galoyan, Karina Galoian

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present research summarizes the protective and immunomodulatory activity of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus (MRSA). The protective effect of galarmin was shown on MRSA-infected animals' survival and weight loss recovery. The immunological impact of galarmin was evaluated in terms of immunocompetent cell recruitment, serum immunoglobulins, complement components C3 and C4, and pro- and anti-inflammatory cytokines (IL-6, IL-8, IL-10, IL-1b, TNFa, and KC) secretion. Galarmin efficiently protects mice against lethal MRSA infection (100% of survival vs. 0% in the untreated group) when intramuscularly injected 24 h before infection and during the 1-h post-infection period at a concentration of 1 ?g per mouse, while its higher concentrations (5 and 10 ?g) were protective when injected in parallel to the infection process. The protective effect of galarmin was not due to a direct effect on MRSA, but should be attributed to an action on the host response to infection. Galarmin significantly increased and modulated the levels of IL-6, IL-8, IL-1b, IL-10, and KC in both peritoneal lavages and blood, leukocyte and platelet counts, lymphocytes percentage, serum IgM and IgG, and complement C3 and C4 components secretion. The experimental results allow concluding that galarmin is a powerful immunomodulatory and protective agent for the in vivo prophylaxis and treatment of MRSA-induced infection.

Original languageEnglish
Pages (from-to)2153-2165
Number of pages13
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume31
Issue number9
DOIs
StatePublished - Sep 1 2012

Fingerprint

PRP-1 peptide
Methicillin-Resistant Staphylococcus aureus
Proline
Peptides
Infection
Complement C4
Complement C3
Interleukin-8
Interleukin-10
Interleukin-6
Peritoneal Lavage
Protective Agents
Serum
Platelet Count
Leukocyte Count
Immunoglobulin M
Immunoglobulins
Weight Loss

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

The protective and immunomodulatory effects of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus infection in mice. / Durgaryan, A. A.; Matevosyan, M. B.; Seferyan, Y.; Sargsyan, M. A.; Grigoryan, S. L.; Galoyan, A. A.; Galoian, Karina.

In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, No. 9, 01.09.2012, p. 2153-2165.

Research output: Contribution to journalArticle

@article{ebcba73b344d4493b4c47a95c4c46a73,
title = "The protective and immunomodulatory effects of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus infection in mice",
abstract = "The present research summarizes the protective and immunomodulatory activity of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus (MRSA). The protective effect of galarmin was shown on MRSA-infected animals' survival and weight loss recovery. The immunological impact of galarmin was evaluated in terms of immunocompetent cell recruitment, serum immunoglobulins, complement components C3 and C4, and pro- and anti-inflammatory cytokines (IL-6, IL-8, IL-10, IL-1b, TNFa, and KC) secretion. Galarmin efficiently protects mice against lethal MRSA infection (100{\%} of survival vs. 0{\%} in the untreated group) when intramuscularly injected 24 h before infection and during the 1-h post-infection period at a concentration of 1 ?g per mouse, while its higher concentrations (5 and 10 ?g) were protective when injected in parallel to the infection process. The protective effect of galarmin was not due to a direct effect on MRSA, but should be attributed to an action on the host response to infection. Galarmin significantly increased and modulated the levels of IL-6, IL-8, IL-1b, IL-10, and KC in both peritoneal lavages and blood, leukocyte and platelet counts, lymphocytes percentage, serum IgM and IgG, and complement C3 and C4 components secretion. The experimental results allow concluding that galarmin is a powerful immunomodulatory and protective agent for the in vivo prophylaxis and treatment of MRSA-induced infection.",
author = "Durgaryan, {A. A.} and Matevosyan, {M. B.} and Y. Seferyan and Sargsyan, {M. A.} and Grigoryan, {S. L.} and Galoyan, {A. A.} and Karina Galoian",
year = "2012",
month = "9",
day = "1",
doi = "10.1007/s10096-012-1550-9",
language = "English",
volume = "31",
pages = "2153--2165",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - The protective and immunomodulatory effects of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus infection in mice

AU - Durgaryan, A. A.

AU - Matevosyan, M. B.

AU - Seferyan, Y.

AU - Sargsyan, M. A.

AU - Grigoryan, S. L.

AU - Galoyan, A. A.

AU - Galoian, Karina

PY - 2012/9/1

Y1 - 2012/9/1

N2 - The present research summarizes the protective and immunomodulatory activity of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus (MRSA). The protective effect of galarmin was shown on MRSA-infected animals' survival and weight loss recovery. The immunological impact of galarmin was evaluated in terms of immunocompetent cell recruitment, serum immunoglobulins, complement components C3 and C4, and pro- and anti-inflammatory cytokines (IL-6, IL-8, IL-10, IL-1b, TNFa, and KC) secretion. Galarmin efficiently protects mice against lethal MRSA infection (100% of survival vs. 0% in the untreated group) when intramuscularly injected 24 h before infection and during the 1-h post-infection period at a concentration of 1 ?g per mouse, while its higher concentrations (5 and 10 ?g) were protective when injected in parallel to the infection process. The protective effect of galarmin was not due to a direct effect on MRSA, but should be attributed to an action on the host response to infection. Galarmin significantly increased and modulated the levels of IL-6, IL-8, IL-1b, IL-10, and KC in both peritoneal lavages and blood, leukocyte and platelet counts, lymphocytes percentage, serum IgM and IgG, and complement C3 and C4 components secretion. The experimental results allow concluding that galarmin is a powerful immunomodulatory and protective agent for the in vivo prophylaxis and treatment of MRSA-induced infection.

AB - The present research summarizes the protective and immunomodulatory activity of hypothalamic proline-rich polypeptide galarmin against methicillin-resistant Staphylococcus aureus (MRSA). The protective effect of galarmin was shown on MRSA-infected animals' survival and weight loss recovery. The immunological impact of galarmin was evaluated in terms of immunocompetent cell recruitment, serum immunoglobulins, complement components C3 and C4, and pro- and anti-inflammatory cytokines (IL-6, IL-8, IL-10, IL-1b, TNFa, and KC) secretion. Galarmin efficiently protects mice against lethal MRSA infection (100% of survival vs. 0% in the untreated group) when intramuscularly injected 24 h before infection and during the 1-h post-infection period at a concentration of 1 ?g per mouse, while its higher concentrations (5 and 10 ?g) were protective when injected in parallel to the infection process. The protective effect of galarmin was not due to a direct effect on MRSA, but should be attributed to an action on the host response to infection. Galarmin significantly increased and modulated the levels of IL-6, IL-8, IL-1b, IL-10, and KC in both peritoneal lavages and blood, leukocyte and platelet counts, lymphocytes percentage, serum IgM and IgG, and complement C3 and C4 components secretion. The experimental results allow concluding that galarmin is a powerful immunomodulatory and protective agent for the in vivo prophylaxis and treatment of MRSA-induced infection.

UR - http://www.scopus.com/inward/record.url?scp=84866426772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866426772&partnerID=8YFLogxK

U2 - 10.1007/s10096-012-1550-9

DO - 10.1007/s10096-012-1550-9

M3 - Article

C2 - 22322358

AN - SCOPUS:84866426772

VL - 31

SP - 2153

EP - 2165

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 9

ER -